Every AI express, investors ask on the investor interaction platform: what is the progress of Zhongke biology and Yunnan Bohui and when they will be put into operation? Please answer the actual progress and planned completion date. Don’t let the wheel’s answer be irrelevant! The company’s operation is so poor that investors are concerned about when there is hope to turn around the loss. Copy and paste empty words again and again is the level of your board secretary?
Beijing Bohui Innovation Biotechnology Group Co.Ltd(300318) ( Beijing Bohui Innovation Biotechnology Group Co.Ltd(300318) . SZ) said on the investor interaction platform on March 11 that the company has been actively promoting the early production of Zhongke biology and Yunnan Qujing project. Due to the need to comprehensively consider the R & D planning of new products and the improvement requirements of existing production processes, as well as the repeated impact of the epidemic, the transformation work lasts for a long time. Yunnan Qujing blood products production base is undergoing equipment installation and commissioning. After the construction is completed, the transfer of production qualification will be started. The transfer of production qualification can be completed only after being accepted and approved by relevant government departments.
